Dare Bioscience, Inc.

Analysis for Ticker: DARE

Dare Bioscience Inc develops medical products for women like contraceptives and health gels, but the actual operation is a machine designed to transfer wealth from the public to lenders. The math is simple and devastating; they sold 100% of the money they would ever make from their only approved drug, XACIATO, to a firm called XOMA for 22$ million. It is as if a landlord sold the right to collect all future rent just to pay for one month of repairs; XOMA will now take 88$ million from the top before shareholders get anything, leaving the company to survive on nothing but debt and the hope of new science it does not even fully own.